High Ki67 index is associated with shorter progression free survival in patients with Follicular Lymphoma treated with frontline immunochemotherapy
Leuk Lymphoma
.
2024 Oct 16:1-4.
doi: 10.1080/10428194.2024.2414899.
Online ahead of print.
Authors
Jianmin Han
1
,
Chad M McCall
2
,
Scott Isom
3
,
Wesley Matthew Smith
4
,
Stephanie Begley
5
,
Dakota Jenneman
6
,
Rupali Bose
5
,
Mary Beth Seegars
4
,
Eric D Hsi
7
,
Nilanjan Ghosh
6
Affiliations
1
Department of Pathology & Laboratory Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
2
Carolinas Pathology Group, Atrium Health Carolinas Medical Center, Charlotte, NC, USA.
3
Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
4
Department of Oncology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
5
Department of Biostatistics and Data Sciences, Atrium Health Levine Cancer Institute, Charlotte, NC, USA.
6
Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC, USA.
7
Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN, USA.
PMID:
39411845
DOI:
10.1080/10428194.2024.2414899
No abstract available